Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of health information technology (HIT) to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients: proceedings from a workshop.
Cohen JD, Aspry KE, Brown AS, Foody JM, Furman R, Jacobson TA, Karalis DG, Kris-Etherton PM, Laforge R, O'Toole MF, Scott RD, Underberg JA, Valuck TB, Willard KE, Ziajka PE, Ito MK. Cohen JD, et al. Among authors: underberg ja. J Clin Lipidol. 2013 Nov-Dec;7(6):573-609. doi: 10.1016/j.jacl.2013.10.002. Epub 2013 Oct 12. J Clin Lipidol. 2013. PMID: 24314357
What is sufficient drug therapy for lipoprotein elevations?
Brown WV, Brown AS, Toth PP, Underberg J. Brown WV, et al. J Clin Lipidol. 2017 Nov-Dec;11(6):1300-1308. doi: 10.1016/j.jacl.2017.10.015. Epub 2017 Oct 31. J Clin Lipidol. 2017. PMID: 29102497 No abstract available.
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV, Underberg JA; NLA Expert Panel. Jacobson TA, et al. Among authors: underberg ja. J Clin Lipidol. 2015 Nov-Dec;9(6 Suppl):S1-122.e1. doi: 10.1016/j.jacl.2015.09.002. Epub 2015 Sep 18. J Clin Lipidol. 2015. PMID: 26699442 Free article.
Genetic effects on efficacy of lipid-lowering drugs.
Brown WV, Brown AS, Ference BA, Toth PP, Underberg JA. Brown WV, et al. Among authors: underberg ja. J Clin Lipidol. 2017 Sep-Oct;11(5):1112-1117. doi: 10.1016/j.jacl.2017.08.010. Epub 2017 Aug 24. J Clin Lipidol. 2017. PMID: 28943038 No abstract available.
JCL roundtable: Risk evaluation and mitigation strategy.
Brown WV, Bramlet DA, Ross JL, Underberg JA. Brown WV, et al. Among authors: underberg ja. J Clin Lipidol. 2016 Nov-Dec;10(6):1288-1296. doi: 10.1016/j.jacl.2016.10.007. Epub 2016 Oct 14. J Clin Lipidol. 2016. PMID: 27919344 Review.
JCL Roundtable: Global Think Tank on Lipoprotein(a).
Maher LL, Tokgözoğlu SL, Sanchez EJ, Underberg JA, Guyton JR. Maher LL, et al. Among authors: underberg ja. J Clin Lipidol. 2021 May-Jun;15(3):387-393. doi: 10.1016/j.jacl.2021.06.003. J Clin Lipidol. 2021. PMID: 34144765
47 results